Veterinary Medicines

NARKAMON BIO 100mg/ml solutie injectabila pentru ,caini ,pisici ,cabaline si magari

Authorised
  • Ketamine hydrochloride
Download as PDF

Product identification

Medicine name:
NARKAMON BIO 100mg/ml solutie injectabila pentru ,caini ,pisici ,cabaline si magari
Active substance:
  • Ketamine hydrochloride
Target species:
  • Dog
  • Horse
  • Mule
  • Cat
Route of administration:
  • Intravenous use
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Ketamine hydrochloride
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Dog
  • Intramuscular use
    • Dog
  • Intravenous use
    • Horse
    • Mule
  • Subcutaneous use
    • Cat
  • Intramuscular use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01AX03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Bioveta Romania S.R.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 200100
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 2/05/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."